Provided by Tiger Fintech (Singapore) Pte. Ltd.

Qudian Inc.

2.74
-0.0600-2.14%
Post-market: 2.73-0.0097-0.35%16:09 EST
Volume:279.93K
Turnover:777.56K
Market Cap:518.97M
PE:102.18
High:2.83
Open:2.80
Low:2.73
Close:2.80
Loading ...

BRIEF-Qudian Reports Third Quarter 2024 Unaudited Financial Results

Reuters
·
22 Nov 2024

Qudian Q3 Adj. EPADS $0.10 Up From $(0.11) YoY, Sales $7.80M Up From $4.06M YoY

Benzinga
·
22 Nov 2024

Qudian Q3 Income From Operations RMB -66.983 Million

THOMSON REUTERS
·
22 Nov 2024

Qudian Incl: Qtrly Adj Net Income per Diluted Ads RMB0.71

THOMSON REUTERS
·
22 Nov 2024

QD Laser Sets Profitability Goal by Fiscal Year 2027 in Mid-Term Plan

MT Newswires Live
·
22 Nov 2024

Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer

GlobeNewswire
·
20 Nov 2024

Oxbridge Re Holdings Among 3 US Penny Stocks To Watch

Simply Wall St.
·
19 Nov 2024

Atea Pharmaceuticals Presents Multiple New Datasets Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD’s The Liver Meeting 2024

GlobeNewswire
·
16 Nov 2024

QD Laser 1H Parent Loss Y303.00M Vs Loss Y250.00M

Dow Jones
·
14 Nov 2024

Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates

GlobeNewswire
·
13 Nov 2024

Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights

PR Newswire
·
08 Nov 2024

PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results

GlobeNewswire
·
07 Nov 2024

Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update

Business Wire
·
07 Nov 2024

C4 Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire
·
31 Oct 2024

Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading

MT Newswires Live
·
30 Oct 2024

Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Pediatric Achondroplasia (BEACH301)

PR Newswire
·
28 Oct 2024